Clarity in the face of confusion: new studies tip the scales on bisphenol A (BPA)

Andrology

Volumn 4, Issue 4, 2016, Pages 561-564

  Vandenberg, L N ^a   Prins, G S ^b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL;

ANDROLOGY; CONFUSION (UNCERTAINTY); CONSUMER; DRUG EXPOSURE; EDITORIAL; FOOD AND DRUG ADMINISTRATION; GOOD LABORATORY PRACTICE; HUMAN; LEACHING; NONHUMAN; PRIORITY JOURNAL; PRODUCT SAFETY;

EID: 84979498525     PISSN: 20472919     EISSN: 20472927     Source Type: Journal    
DOI: 10.1111/andr.12219     Document Type: Editorial

References (29)

1. Agrawal DK, Arevalo M, Bhalla S, Chai Chivatsi D, Gamaniel KS, Kulshrestha S, Long D, Martinez L, Mbugua PN, Moshi MJ, Murilla G, Ngotho M, Rajashekher G, Rukunga G, Sanogo R, Srivastava S, Titanji VPK, Walubo A, Yole D & Zalis M (2009). Handbook: good laboratory practice (GLP): quality practices for regulated non-chemical research and development. 2nd edn (eds Kioy D, Long D, Bhalla S & Seiler J) World Health Organization Library, Cataloguing-in-Publication Data. UNDP/World Bank/WHO Special programme for research and training in tropical diseases, Switzerland.
2. Bergman A, Andersson AM, Becher G, van den Berg M, Blumberg B, Bjerregaard P, Bornehag CG, Bornman R, Brandt I, Brian JV, Casey SC, Fowler PA, Frouin H, Giudice LC, Iguchi T, Hass U, Jobling S, Juul A, Kidd KA, Kortenkamp A, Lind M, Martin OV, Muir D, Ochieng R, Olea N, Norrgren L, Ropstad E, Ross PS, Ruden C, Scheringer M, Skakkebaek NE, Soder O, Sonnenschein C, Soto A, Swan S, Toppari J, Tyler CR, Vandenberg LN, Vinggaard AM, Wiberg K & Zoeller RT. (2013a) Science and policy on endocrine disrupters must not be mixed: a reply to a “common sense” intervention by toxicology journal editors. Environ Health 12, 69.
3. Bergman A, Heindel JJ, Kasten T, Kidd KA, Jobling S, Neira M, Zoeller RT, Becher G, Bjerregaard P, Bornman R, Brandt I, Kortenkamp A, Muir D, Drisse MN, Ochieng R, Skakkebaek NE, Bylehn AS, Iguchi T, Toppari J & Woodruff TJ. (2013b) The impact of endocrine disruption: a consensus statement on the state of the science. Environ Health Perspect 121, A104–A106.
4. Bergman A, Becher G, Blumberg B, Bjerregaard P, Bornman R, Brandt I, Casey SC, Frouin H, Giudice LC, Heindel JJ, Iguchi T, Jobling S, Kidd KA, Kortenkamp A, Lind PM, Muir D, Ochieng R, Ropstad E, Ross PS, Skakkebaek NE, Toppari J, Vandenberg LN, Woodruff TJ & Zoeller RT. (2015) Manufacturing doubt about endocrine disrupter science - A rebuttal of industry-sponsored critical comments on the UNEP/WHO report “State of the Science of Endocrine Disrupting Chemicals 2012”. Regul Toxicol Pharmacol 73, 1007–1017.
5. Diamanti-Kandarakis E, Bourguignon JP, Guidice LC, Hauser R, Prins GS, Soto AM, Zoeller RT & Gore AC. (2009) Endocrine-disrupting chemical: an endocrine society scientific statement. Endocr Rev 30, 293–342.
6. Frye CA, Bo E, Calamandrei G, Calza L, Dessi-Fulgheri F, Fernandez M, Fusani L, Kah O, Kajta M, Le Page Y, Patisaul HB, Venerosi A, Wojtowicz AK & Panzica GC. (2012) Endocrine disrupters: a review of some sources, effects, and mechanisms of actions on behaviour and neuroendocrine systems. J Neuroendocrinol 24, 144–159.
7. Geens T, Aerts D, Berthot C, Bourguignon JP, Goeyens L, Lecomte P, Maghuin-Rogister G, Pironnet AM, Pussemier L, Scippo ML, Van Loco J & Covaci A. (2012) A review of dietary and non-dietary exposure to bisphenol-A. Food Chem Toxicol 50, 3725–3740.
8. Gore AC, Balthazart J, Bikle D, Carpenter DO, Crews D, Czernichow P, Diamanti-Kandarakis E, Dores RM, Grattan D, Hof PR, Hollenberg AN, Lange C, Lee AV, Levine JE, Millar RP, Nelson RJ, Porta M, Poth M, Power DM, Prins GS, Ridgway EC, Rissman EF, Romijn JA, Sawchenko PE, Sly PD, Soder O, Taylor HS, Tena-Sempere M, Vaudry H, Wallen K, Wang Z, Wartofsky L, & Watson CS. (2013) Policy decisions on endocrine disruptors should be based on science across disciplines: a response to dietrich Endocrinology 154, 3957–3960.
9. Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS, Toppari J & Zoeller RT. (2015) EDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals. Endocr Rev 36, E1–E150.
10. Hass U, Christiansen S, Boberg J, Rasmussen MG, Mandrup K & Axelstad M (2016) Low-dose effect of developmental bisphenol-A exposure on sperm count and behaviour in rats. Andrology DOI: 10.1111/andr.12176.
11. Mandrup K, Boberg J, Krag Isling L, Christiansen S & Hass U (2016) Low-dose effects of bisphenol A on mammary gland development in rats. Andrology DOI: 10.1111/andr.12193.
12. Michaels D. (2006) Manufactured uncertainty: protecting public health in the age of contested science and product defense. Ann N Y Acad Sci 1076, 149–162.
13. Myers JP, Vom Saal FS, Akingbemi BT, Arizono K, Belcher S, Colborn T, Chahoud I, Crain DA, Farabollini F, Guillette LJ, Hassold T, Ho S-M, Hunt PA, Iguchi T, Jobling S, Kanno J, Laufer H, Marcus M, McLachlan JA, Nadal A, Oehlmann J, Olea N, Palanza P, Parmigiani S, Rubin BS, Schonfelder G, Sonnenschein C, Soto AM, Talsness CE, Taylor JA, Vandenberg LN, Vandenbergh JG, Vogel S, Watson CS, Welshons WV & Zoeller RT (2009a) Why public health agencies cannot depend upon ‘Good Laboratory Practices’ as a criterion for selecting data: the case of bisphenol-A. Environ Health Perspect 117, 309–315.
14. Myers JP, Zoeller RT & vom Saal FS. (2009b) A clash of old and new scientific concepts in toxicity, with important implications for public health. Environ Health Perspect 117, 1652–1655.
15. Oreskes N, Carlat D, Mann ME, Thacker PD & vom Saal FS. (2015) Viewpoint: why disclosure matters. Environ Sci Technol 49, 7527–7528.
16. Peretz J, Vrooman L, Ricke WA, Hunt PA, Ehrlich S, Hauser R, Padmanabhan V, Taylor HS, Swan SH, VandeVoort CA & Flaws JA. (2014) Bisphenol a and reproductive health: update of experimental and human evidence, 2007–2013. Environ Health Perspect 122, 775–786.
17. Richter C, Birnbaum LS, Farabollini F, Newbold RR, Rubin BS, Talsness CE, Vandenbergh JG, Walser-Kuntz DR & vom Saal FS. (2007) In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 24, 199–224.
18. Rochester JR. (2013) Bisphenol A and human health: a review of the literature. Reprod Toxicol 42C, 132–155.
19. Rochester JR & Bolden AL. (2015) Bisphenol S and F: a systematic review and comparison of the hormonal activity of bisphenol A substitutes. Environ Health Perspect 123, 643–650.
20. vom Saal FS, Akingbemi BT, Belcher SM, Birnbaum LS, Crain DA, Eriksen M, Farabollini F, Guillette LJ, Hauser R Jr, Heindel JJ, Ho SM, Hunt PA, Iguchi T, Jobling S, Kanno J, Keri RA, Knudsen KE, Laufer H, LeBlanc GA, Marcus M, McLachlan JA, Myers JP, Nadal A, Newbold RR, Olea N, Prins GS, Richter CA, Rubin BS, Sonnenschein C, Soto AM, Talsness CE, Vandenbergh JG, Vandenberg LN, Walser-Kuntz DR, Watson CS, Welshons WV, Wetherill Y & Zoeller RT (2007) Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol 24, 131–138.
21. Seachrist DD, Bonk KW, Ho SM, Prins GS, Soto AM & Keri RA. (2016) A review of the carcinogenic potential of bisphenol A. Reprod Toxicol 59, 167–182.
22. Vandenberg LN (2011) Exposure to bisphenol A in Canada: invoking the precautionary principle. CMAJ 183, 1265–1270.
23. Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS & Soto AM. (2009) Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 30, 75–95.
24. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr, Lee DH, Shioda T, Soto AM, vom Saal FS, Welshons WV, Zoeller RT & Myers JP. (2012) Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 33, 378–455.
25. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR, Lee DH, Myers JP, Shioda T, Soto AM, Vom Saal FS, Welshons WV & Zoeller RT. (2013a) Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology. Reprod Toxicol 38C, 1–15.
26. Vandenberg LN, Ehrlich S, Belcher SM, Ben-Jonathan N, Dolinoy DC, Hugo ER, Hunt PA, Newbold RR, Rubin BS, Saili KS, Soto AM, Wang HS & Vom Saal FS. (2013b) Low dose effects of Bisphenol A: an integrated review of in vitro, laboratory animal and epidemiology studies. Endocrine Disruptors 1, e25078.
27. Vandenberg LN, Luthi D & Quinerly D (2015) Plastic bodies in a plastic world: multi-disciplinary approaches to study endocrine disrupting chemicals. J Cleaner Production DOI: 10.1016/j.jclepro.2015.01.071.
28. Woodruff TJ, Zeise L, Axelrad DA, Guyton KZ, Janssen S, Miller M, Miller GG, Schwartz JM, Alexeeff G, Anderson H, Birnbaum L, Bois F, Cogliano VJ, Crofton K, Euling SY, Foster PM, Germolec DR, Gray E, Hattis DB, Kyle AD, Luebke RW, Luster MI, Portier C, Rice DC, Solomon G, Vandenberg J & Zoeller RT. (2008) Meeting report: moving upstream-evaluating adverse upstream end points for improved risk assessment and decision-making. Environ Health Perspect 116, 1568–1575.
29. Zoeller RT, Brown TR, Doan LL, Gore AC, Skakkebaek NE, Soto AM, Woodruff TJ & Vom Saal FS. (2012) Endocrine-disrupting chemicals and public health protection: a statement of principles from the endocrine society. Endocrinology 153, 4097–4110.